
P · NYSE
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2021 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.66B | $3.17B | $2.83B | $2.75B | $2.18B | $1.68B | $1.64B | $1.36B |
| Cost of Revenue | $1.08B | $955.46M | $809.43M | $855.79M | $708.33M | $535.25M | $509.89M | $457.53M |
| Gross Profit | $2.58B | $2.21B | $2.02B | $1.90B | $1.47B | $1.15B | $1.13B | $902.30M |
| Research & Development | $963.29M | $804.40M | $736.76M | $692.53M | $581.93M | $480.47M | $433.66M | $349.94M |
| Selling, General & Administrative | $318.36M | $286.23M | $252.24M | $238.00M | $189.98M | $182.48M | $163.15M | $137.51M |
| Operating Expenses | $2.46B | $2.13B | $1.97B | $1.81B | $1.57B | $1.41B | $1.32B | $1.07B |
| Operating Income | $114.82M | $85.26M | $53.55M | $83.51M | -$98.40M | -$261.03M | -$191.28M | -$169.26M |
| Interest Expense | — | — | $7.48M | $4.75M | $36.68M | $31.40M | $27.90M | $21.61M |
| Other Income / (Expense) | $109.47M | $62.58M | $37.03M | $8.29M | -$30.10M | -$9.13M | -$3.38M | -$8.02M |
| Income Before Taxes | $224.28M | $147.83M | $90.59M | $91.81M | -$128.50M | -$270.16M | -$194.67M | -$177.27M |
| Provision for Income Taxes | $36.10M | $41.09M | $29.27M | $18.74M | $14.76M | $11.92M | $6.32M | $1.09M |
| Net Income | $188.18M | $106.74M | $61.31M | $73.07M | -$143.26M | -$282.08M | -$200.99M | -$178.36M |
| Basic EPS | $0.57 | $0.33 | $0.20 | $0.24 | -$0.50 | -$1.05 | -$0.79 | — |
| Diluted EPS | $0.55 | $0.31 | $0.19 | $0.23 | -$0.50 | -$1.05 | -$0.79 | — |
| Basic Shares Outstanding | 328.54M | 325.77M | 311.83M | 299.48M | 285.88M | 267.82M | 252.82M | — |
| Diluted Shares Outstanding | 342.99M | 342.70M | 332.57M | 339.18M | 285.88M | 267.82M | 252.82M | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $0.96 | $0.78 | $1.18 | 8 | ↑6 ↓2 |
| Jan 2028 | $1.62 | $0.71 | $2.22 | 8 | ↑5 ↓3 |
| Jan 2029 | $2.16 | $2.16 | $2.16 | 1 | ↑1 ↓0 |